A Case Report of a Patient with Turner Syndrome, Multiple Comorbidities, and Pustular Psoriasis: Correlation or Coincidence?

Turner syndrome (TS) is one of the most common chromosomal abnormalities. Patients with TS are at an increased risk for the development of metabolic syndrome, hypertension (HTN), diabetes mellitus type II (DM2), hyperlipidemia (HLD), obesity, and cardiovascular disease. The association between psoriasis and the aforementioned conditions including metabolic syndrome, HTN, HLD, obesity, and cardiovascular disease has also been established. Although the mechanism for heightened risk in TS patients is yet to be elucidated, patients suffering from TS and cardiometabolic diseases are likely to be at an even higher risk for developing psoriasis than patients suffering from TS alone. We present a case of a 53-year-old Hispanic woman with a mosaic TS and multiple comorbidities who presented with pustular psoriasis. For this patient, management can be challenging considering her numerous medical comorbidities and the presence of both TS and psoriasis.

[1]  J. Lee,et al.  Metabolic syndrome is associated with an increased risk of psoriasis: a nationwide population-based study. , 2019, Metabolism: clinical and experimental.

[2]  M. Geffner,et al.  Cardiometabolic health in Turner syndrome , 2019, American journal of medical genetics. Part C, Seminars in medical genetics.

[3]  R. Sarpong,et al.  Bio-inspired synthesis of xishacorenes A, B, and C, and a new congener from fuscol† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc02572c , 2019, Chemical science.

[4]  U. Pagotto,et al.  New insights on diabetes in Turner syndrome: results from an observational study in adulthood , 2018, Endocrine.

[5]  S. Shalitin,et al.  The Natural History of Metabolic Comorbidities in Turner Syndrome from Childhood to Early Adulthood: Comparison between 45,X Monosomy and Other Karyotypes , 2018, Front. Endocrinol..

[6]  G. Conway,et al.  The Turner syndrome life course project: Karyotype‐phenotype analyses across the lifespan , 2017, Clinical endocrinology.

[7]  Olaf M Dekkers,et al.  Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. , 2017, European journal of endocrinology.

[8]  M. Isobe,et al.  Generalized pustular psoriasis associated with Turner syndrome and dilated cardiomyopathy , 2016, The Journal of dermatology.

[9]  D. Larizza,et al.  Metabolic syndrome in Turner syndrome and relation between body composition and clinical, genetic, and ultrasonographic characteristics. , 2014, Metabolic syndrome and related disorders.

[10]  J. Hamilton,et al.  An evaluation of early cardiometabolic risk factors in children and adolescents with Turner syndrome , 2013, Clinical endocrinology.

[11]  J. Gelfand,et al.  Metabolic Syndrome in Patients with Psoriatic Disease , 2012, The Journal of Rheumatology. Supplement.

[12]  刘敏.  Approach to the patient with Turner syndrome , 2010 .

[13]  M. Davenport,et al.  Approach to the patient with Turner syndrome. , 2010, The Journal of clinical endocrinology and metabolism.

[14]  M. Pompili,et al.  Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. , 2009, Journal of hepatology.

[15]  C. Bondy,et al.  X-chromosome gene dosage and the risk of diabetes in Turner syndrome. , 2009, Journal of Clinical Endocrinology and Metabolism.

[16]  B. Strober,et al.  Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. , 2009, Journal of the American Academy of Dermatology.

[17]  A. Kawada,et al.  Pustular psoriasis and vitiligo in a patient with Turner syndrome , 2007, The Journal of dermatology.

[18]  L. Wilhelmsen,et al.  Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome , 2007, Clinical endocrinology.

[19]  C. Bondy,et al.  Monosomy for the X-chromosome is associated with an atherogenic lipid profile. , 2006, The Journal of clinical endocrinology and metabolism.

[20]  A. Bowcock,et al.  Getting under the skin: the immunogenetics of psoriasis , 2005, Nature Reviews Immunology.

[21]  M. Magnanini,et al.  Turner's syndrome associated with psoriasis and alopecia areata , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[22]  M. Ranke,et al.  Turner's syndrome , 2001, The Lancet.

[23]  C. Gravholt,et al.  Morbidity in Turner syndrome. , 1998, Journal of clinical epidemiology.

[24]  W. S. Lee,et al.  Alopecia areata in a patient with Turner's syndrome , 1996, The British journal of dermatology.

[25]  J. Burnett,et al.  Widespread lichen planus in association with Turner's syndrome and multiple endocrinopathies. , 1994, Cutis.

[26]  P. Gisondi,et al.  Psoriasis and the metabolic syndrome. , 2018, Clinics in dermatology.

[27]  W. Marsden.  I and J , 2012 .

[28]  D. Zahger,et al.  Psoriasis and the metabolic syndrome. , 2007, Acta dermato-venereologica.

[29]  T. J. Gargan.  Turner's syndrome. , 1997, The New England journal of medicine.